Furosemide and Spironolactone are diuretics often combined to treat conditions related to fluid overload, such as hypertension and edema. Furosemide is a loop diuretic, while Spironolactone is a potassium-sparing diuretic. Together, they help manage fluid balance and blood pressure.
The combination of Furosemide and Spironolactone is used for:
| Brand Name | Furotone |
|---|---|
| Type | Tablet |
| Weight | 20 mg+50 mg |
| Generic | Furosemide + Spironolactone |
| Manufacturer | Novo Healthcare and Pharma Ltd. |
| Available in | English বাংলা |
Furosemide acts as a loop diuretic by inhibiting the sodium-potassium-chloride cotransporter in the ascending loop of Henle in the kidney, which increases sodium, potassium, and chloride excretion. Spironolactone is a potassium-sparing diuretic that works by antagonizing aldosterone in the distal convoluted tubule and collecting ducts, promoting sodium and water excretion while retaining potassium.
Furosemide typically begins to act within 1 hour of oral administration, with peak effects occurring in 1 to 2 hours. Spironolactone takes longer, usually 2 to 4 days to achieve its full effect. When used together, the diuretic effects are often noticed within a few hours, but the combined benefits may take a few days to become fully apparent.
Furosemide is well absorbed from the gastrointestinal tract with a bioavailability of about 50% to 70%. Spironolactone is also well absorbed, with a bioavailability of about 90%. Food can affect the absorption rate, but not significantly.
Furosemide is primarily eliminated via the kidneys, with approximately 60% to 90% of the drug excreted unchanged in the urine. Spironolactone is metabolized in the liver to active metabolites and then excreted mainly via the kidneys. A small amount is also excreted in the feces.
The dosage for the combination of Furosemide and Spironolactone can vary based on the condition being treated:
Both Furosemide and Spironolactone are usually administered orally in tablet form. They should be taken with or after meals to minimize gastrointestinal irritation. Consistent dosing times each day are recommended to maintain effective diuretic action.
Common side effects include:
Toxicity can occur with excessive doses or in patients with compromised renal function. Symptoms of toxicity may include severe electrolyte imbalances, profound dehydration, or kidney damage. Immediate medical attention is required in such cases.
Precautions should be observed in patients with:
Interactions may include:
Interactions with diseases may include:
Drug interactions include:
No significant food interactions have been reported with Furosemide and Spironolactone. However, maintaining a balanced diet and monitoring potassium intake is important during treatment.
Furosemide and Spironolactone are classified as category C drugs for pregnancy. They should only be used if the benefits outweigh the risks. Both medications can affect fetal electrolyte balance and renal function.
Both Furosemide and Spironolactone are excreted in breast milk. Use during lactation should be avoided or used with caution, depending on the clinical need. The potential effects on the infant should be considered.
Acute overdose can result in severe electrolyte imbalances, dehydration, hypotension, and renal failure. Treatment involves symptomatic management, electrolyte replacement, and supportive care. Immediate medical attention is crucial.
Contraindications include:
Take Furosemide and Spironolactone exactly as prescribed. Follow dosing instructions and frequency as directed by the healthcare provider. Regular monitoring of electrolytes and renal function is necessary.
Store Furosemide and Spironolactone at room temperature, away from light and moisture. Keep the medications tightly closed and out of reach of children.
The volume of distribution for Furosemide is approximately 0.1 to 0.2 L/kg, while for Spironolactone, it is about 0.4 to 0.7 L/kg. This indicates the extent to which the drugs are distributed throughout body tissues.
The half-life of Furosemide is approximately 1 to 2 hours, while Spironolactone has a half-life of 1.4 to 2 hours. The active metabolites of Spironolactone have a longer half-life, contributing to the prolonged effect.
Furosemide is cleared primarily by the kidneys with a clearance rate of 100 to 150 mL/min. Spironolactone is also cleared through renal excretion, with its active metabolites having a slower clearance rate, contributing to its extended duration of action.
See in details version Furotone Tablet 20 mg+50 mg also Furotone Tablet 20 mg+50 mg in bangla